Huntington’s Disease Studies

If you think you may qualify for one of these studies, please contact CNI’s Research Department at 303-806-7423.

2Care: COENYZME Q10 IN HUNTINGTON’S DISEASE (HD): To assess the effects of CoQ on the progression of functional decline in HD
eligibility and information
Principal Investigator: Rajeev Kumar, MD

A Prospective Registry Study in a Global Huntington’s Disease Cohort: To improve the understanding of the dynamic phenotypic spectrum and the disease mechanisms of HD
eligibility and information
Principal Investigator: Rajeev Kumar, MD

The PREDICT-HD Study: To define the neurobiology of Huntington disease (HD) and to develop tools to allow clinical trials of potential disease-modifying therapies before at-risk individuals have diagnosable symptoms of the disease.
eligibility and information
Principal Investigator: Rajeev Kumar, MD

 

Colorado Neurological Insitute